The Fort Worth Press - Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4

USD -
AED 3.672505
AFN 64.502368
ALL 81.998222
AMD 357.803769
ANG 1.790403
AOA 918.000351
ARS 1559.243988
AUD 1.491024
AWG 1.8025
AZN 1.697591
BAM 1.782854
BBD 2.012735
BDT 124.411466
BGN 1.77347
BHD 0.377107
BIF 3003.463993
BMD 1
BND 1.288879
BOB 11.707704
BRL 5.899
BSD 0.999385
BTN 93.383593
BWP 14.117915
BYN 2.997958
BYR 19600
BZD 2.009818
CAD 1.431095
CDF 2285.00014
CHF 0.842915
CLF 0.025574
CLP 1006.490009
CNY 6.667797
CNH 6.668405
COP 3354.71
CRC 444.296568
CUC 1
CUP 23.984575
CVE 100.51779
CZK 22.22175
DJF 177.949763
DKK 6.802565
DOP 60.418499
DZD 137.053072
EGP 53.820098
ERN 15
ETB 164.020438
EUR 0.91005
FJD 2.28525
FKP 0.76038
GBP 0.760375
GEL 2.590602
GGP 0.76038
GHS 11.732317
GIP 0.76038
GMD 73.499493
GNF 8859.697901
GTQ 7.637401
GYD 209.002981
HKD 7.844715
HNL 26.862474
HRK 6.831965
HTG 131.020966
HUF 335.920292
IDR 18253
ILS 3.282095
IMP 0.76038
INR 93.28535
IQD 1514.984389
IRR 1933164.496166
ISK 124.679944
JEP 0.76038
JMD 158.502846
JOD 0.709056
JPY 159.949498
KES 130.060512
KGS 87.449537
KHR 4071.103008
KMF 448.999585
KPW 900.00035
KRW 1328.189719
KWD 0.31162
KYD 0.832836
KZT 444.440393
LAK 22515.053033
LBP 89590.84067
LKR 332.58429
LRD 167.887437
LSL 17.179374
LTL 2.95274
LVL 0.60489
LYD 6.463111
MAD 9.953508
MDL 18.347645
MGA 4544.315048
MKD 55.964687
MMK 2099.801407
MNT 3600.814049
MOP 8.076574
MRU 40.612196
MUR 46.840266
MVR 15.416238
MWK 1732.793079
MXN 18.845105
MYR 4.113204
MZN 63.915562
NAD 17.179061
NGN 1351.659682
NIO 36.77352
NOK 9.693335
NPR 149.412703
NZD 1.80985
OMR 0.384501
PAB 0.999385
PEN 3.411744
PGK 4.495877
PHP 63.690193
PKR 276.292258
PLN 4.01981
PYG 6255.270079
QAR 3.643308
RON 4.864696
RSD 107.053982
RUB 81.823857
RWF 1478.922348
SAR 3.751382
SBD 8.137041
SCR 13.883305
SDG 601.50065
SEK 10.14478
SGD 1.289585
SHP 0.757117
SLE 22.795018
SLL 20969.503664
SOS 571.095199
SRD 37.384497
STD 20697.981008
STN 22.333535
SVC 8.744046
SYP 13002.000337
SZL 17.176326
THB 33.896501
TJS 9.188906
TMT 3.5
TND 3.026701
TOP 2.40776
TRY 50.46722
TTD 6.7815
TWD 32.936502
TZS 2655.017981
UAH 45.116247
UGX 4186.987794
UYU 40.602566
UZS 12002.151381
VES 916.62795
VND 25755
VUV 120.949122
WST 2.823281
XAF 596.953744
XAG 0.022206
XAU 0.000268806004
XCD 2.70255
XCG 1.801044
XDR 0.707052
XOF 596.953744
XPF 108.71765
YER 236.550276
ZAR 17.251035
ZMK 9001.198647
ZMW 20.525699
ZWL 321.999592
SSP 5879.599296
MXV 2.113026
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4
Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4

Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4

270% Net Income Jump, $300K+ Q4 Private Sales, and $250,000 Software Agreement Underpin Decision to Suspend Equity Issuance Through 2027

Text size:

MESA, AZ / ACCESS Newswire / November 19, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that it has paused dilution and does not currently plan to resume equity issuance until 2027 when expansion plans and funding are to be re-evaluated in efforts to align with shareholder value and continuing near term revenue. The decision follows the Company's third-quarter results showing a sharp improvement in profitability and accelerating private sales activity at its Infinite Auctions subsidiary.

On November 12, MDCE reported unaudited results for the three and nine months ended September 30, 2026. Third-quarter sales revenue rose 13% to $538,981. Gross profit increased 55% to $240,839. Net operating income rose 254% to $192,565, and net income increased 270% to $192,565. For the nine-month period, the Company reported net income of $198,883 compared to a net loss of $145,347 in the prior-year period. Gross profit rose to $332,744. The Company ended the quarter with zero current liabilities and cash of $102,172.

Supporting the decision to pause dilution is revenue generation at Infinite Auctions. Private sales at the subsidiary have already surpassed $300,000 in the fourth quarter. This activity builds on the subsidiary's partnership with a multi-billion-dollar sports card and collectibles company, under which six-figure transaction activity has already occurred. Real Game Used continues to maintain a continuous backlog of customer and auction-brand authentication work through its automated submission system. The Company has also announced that its subsidiaries are managing approximately $20 million in private collectibles assets, with potential net profits contingent on completed sales.

In parallel, technical development continues under MDCE's first paid external software agreement, valued at up to $250,000, covering an integrated web and enterprise platform for inventory and sales workflows. The first payment under that agreement has been initiated. StrainScan Pro enterprise demonstrations remain active. Internal evaluation continues on MDCE Melanoma Scan Beta and the wound-monitoring application, with updated technical results available on the Company's corporate website.

"Shareholders have expressed concern about dilution and this is our response," said Marshall Perkins, CEO of Medical Care Technologies. "The third-quarter results showed net income up 270% and a clear improvement in profitability. Infinite Auctions private sales have already surpassed $300,000 in Q4. That revenue, together with the software agreement now in active development and the ongoing work at our subsidiaries, gives us the ability to pause further equity issuance through 2027. The focus is on building from the commercial activity we already have in motion."

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company owns subsidiaries Infinite Auctions and Real Game Used. Visit: medicalcaretechnologies.com | infiniteauctions.com | realgameused.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and projections about the Company's business and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Such risks include the Company's ability to continue generating revenue from subsidiaries and software activities, complete development under existing agreements, sustain private sales activity, and manage its capital structure. Any decision to pause or resume equity issuance is subject to change based on operating results, capital needs, and other factors. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law. Investors are cautioned not to place undue reliance on these forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: [email protected]
Website: medicalcaretechnologies.com

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire

S.Jordan--TFWP